Results 81 to 90 of about 4,640,867 (405)

Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study

open access: yesSignal Transduction and Targeted Therapy, 2021
Our understanding of the protective immunity, particularly the long-term dynamics of neutralizing antibody (NAbs) response to SARS-CoV-2, is currently limited.
Xin Xu   +13 more
doaj   +1 more source

Histopathological Changes in the Kidney following Congestive Heart Failure by Volume Overload in Rats [PDF]

open access: yes, 2017
Background. This study investigated histopathological changes and apoptotic factors that may be involved in the renal damage caused by congestive heart failure in a rat model of infrarenal aortocaval fistula (ACF). Methods.
Aboryag, Noureddin B.   +7 more
core   +4 more sources

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

Mortality and Recovery Associated with Kidney Failure Due to Acute Kidney Injury.

open access: yesAmerican Society of Nephrology. Clinical Journal, 2020
BACKGROUND AND OBJECTIVES AKI requiring dialysis is a contributor to the growing burden of kidney failure, yet little is known about the frequency and patterns of recovery of AKI and its effect on outcomes in patients on incident dialysis.
Silvi Shah   +5 more
semanticscholar   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Association of Age With Risk of Kidney Failure in Adults With Stage IV Chronic Kidney Disease in Canada

open access: yesJAMA Network Open, 2020
This cohort study examines the competing risks of death and kidney failure in an aging population with or without age-related comorbid conditions.
P. Ravani   +10 more
semanticscholar   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Association of iron deficiency with kidney outcome and all-cause mortality in chronic kidney disease patients without anemia

open access: yesNutrition Journal
Background Iron deficiency is prevalent in patients with chronic kidney disease (CKD), even in those without anemia. However, the effects of iron deficiency on CKD progression and all-cause mortality in non-dialysis-dependent CKD (NDD-CKD) patients ...
Hongxue Yu   +11 more
doaj   +1 more source

Association Between New-Onset Proteinuria During Hospitalization and Cardiovascular Mortality Among Patients With Atherosclerotic Cardiovascular Disease

open access: yesJACC: Advances
Background: Evidence regarding the prognostic value of new-onset proteinuria during hospitalization among patients with atherosclerotic cardiovascular disease (ASCVD) is lacking.
Licong Su, MD   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy